H. Abali And I. Celik, "High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel," AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.25, no.6, pp.632-633, 2002
Abali, H. And Celik, I. 2002. High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.25, no.6 , 632-633.
Abali, H., & Celik, I., (2002). High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.25, no.6, 632-633.
Abali, H, And İSMAİL ÇELİK. "High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel," AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.25, no.6, 632-633, 2002
Abali, H And Celik, İSMAİL. "High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.25, no.6, pp.632-633, 2002
Abali, H. And Celik, I. (2002) . "High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.25, no.6, pp.632-633.
@article{article, author={H Abali And author={İSMAİL ÇELİK}, title={High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel}, journal={AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS}, year=2002, pages={632-633} }